Peer-influenced content. Sources you trust. No registration required. This is HCN.
Hematology Advisor
New research indicates that maternal hemoglobin levels can significantly impact both maternal and neonatal health outcomes, suggesting a need for revised antenatal care guidelines.
Hematology September 11th 2023
This study provides new insights into using electronic health records as an efficient tool for predicting survival outcomes in SCA treatment, highlighting the significant role of hydroxyurea in lowering mortality rates.
Hematology September 5th 2023
ReachMD
Enhance your clinical decision-making skills in the management of ESA-refractory LR-MDS. Register now for actionable insights and the latest research findings.
Clinical Pharmacology September 5th 2023
Clinical Advisor
The use of reticulocyte hemoglobin content (CHr) presents a significant advancement in diagnosing iron-deficiency anemia. CHr’s potential in early detection, differentiation of hematologic conditions, and real-time assessment could pave the way for more precise and timely patient care.
Hematology August 1st 2023
Annals of Internal Medicine
Recent findings suggest a link between daily low-dose aspirin intake and elevated anemia incidence and ferritin decline in older adults, highlighting the necessity for periodic monitoring of hemoglobin in these patients.
Geriatrics June 29th 2023
Blood
In this “Letters to Blood,” the author demonstrated that luspatercept provided prolonged periods of transfusion independence (TI), significantly decreased the transfusion burden among HTB and LTB patients, and generally had an acceptable and predictable safety profile, all of which helped to maintain or enhance patient quality of life. Compared to the results from the primary analysis, these data further demonstrate the clinical benefits of luspatercept in patients with LR-MDS-RS.
Hematology December 5th 2022